Journal articleCancer Cell2022
Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer.
- Journal
- Cancer Cell
- Published
- 3 February 2022
- Citations
- 293
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 9
- Targeting malic enzyme 3 as a synthetic lethality target in pancreatic cancer K99CA218891↗
- Core C-Computational Core P01CA117969↗
- Mouse Tumor Model Shared Resource P30CA016056↗
- Stem Cell Biology & Cellular Therapy Program P30CA016672↗
- Administrative Core P50CA221707↗
- Targeting Malic Enzyme 3 as a Synthetic Lethality Target in Pancreatic Cancer R00CA218891↗
- Translational Applications in an Animal Model of Pancreatic Cystic Neoplasm and Cancer R01CA218004↗
- Exploring Collateral Lethality for Development of Cancer Therapeutics R01CA225955↗
- Role of type 2 immune response in pancreatic cancer tumorigenesis R01CA262822↗